Posted by Logan Wallace on Feb 14th, 2026
Avita Medical (NASDAQ:RCEL) reported fourth-quarter revenue of $17.6 million and full-year 2025 revenue of approximately $71.6 million, representing about 11% growth over 2024 and landing in line with the company’s updated guidance,...
More of this article »